Boston Scientific announces acquisition of nVision Medical for $275 million
Boston Scientific announced it has acquired nVision Medical Corporation, a privately-held company focused on women's health. The transaction consists of an upfront cash payment of $150 million, and up to an additional $125 million in potential clinical and commercial milestones over four years. April 16, 2018